Valmet Receives Order to Upgrade Five Lee & Man Tissue Machines in China

Reuters
Dec 18, 2025
Valmet Receives Order to Upgrade Five Lee & Man Tissue Machines in China

Valmet Oyj has announced that it has received an order from Lee & Man Paper Manufacturing Ltd. in China to upgrade five tissue machines with its Advantage ViscoNip press technology. The order covers the replacement of existing shoe presses on tissue machines TM 3, 9, 10, 11, and 12 at mills in Chongqing, Jiangxi, and Guangdong. The value of the order has not been disclosed. The upgrades, which include an upgrade package and related services, are expected to be operational during 2026. The order was partly included in Valmet's second quarter 2025 orders received and mostly in the fourth quarter 2025 orders received. The new technology aims to enhance pressing performance, improve machine efficiency, reduce maintenance needs, and support higher-quality tissue production.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valmet Oyj published the original content used to generate this news brief on December 18, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10